Dmytro Shymkiv is a top executive, entrepreneur, and investor with over 20 years of experience in innovative industries across Ukraine, Europe, and North America. He is Co-Founder and Business Development Director at AeroDrone - Ukrainian start-up that specializes in the design, development, and manufacturing of unmanned aircraft systems (UAS) capable of heavy lifting, long-range flights, and extended endurance. These UAS are used in various industries, including military, and have been designed for both special missions (logistics, communications, relaying) and combat missions (reconnaissance, targeting, radio-electronic warfare, striking with missiles and bombs).

The company's flagship UAS models are the D80-Discovery and E300-Enterprise, which can respectively carry up to 80 kg and 300 kg of total payload (including fuel) for distances of up to 900 km (D80) and 3150 km (E300), depending on the fuel system design and carried load. Both models can perform fully autonomous flights with pre-programmed missions, from takeoff to landing, with automatic and manual in-flight control for the aircraft and its payloads. The UAS can take off and land on any flat terrain. AeroDrone's UAS models have been approved for use in the Ukrainian Armed Forces and since 2022 the company has been fulfilling contracts for the Ukrainian Ministry of Defense.

Dmytro Shymkiv is also an independent member of the Supervisory Board of Kyivstar, Ukraine's largest telecom operator, and represents the company on the board of directors of Helsi, a Ukrainian largest medical information system provider. He is also an independent member of the Supervisory Board of the Ukrainian Startup Fund, a state pre-seed and seed fund supporting early-stage technological and defense (Brave1) startups and is Ukraine's largest angel investor. Dmytro Shymkiv has held high-profile leadership positions, including General Manager of Microsoft Ukraine (2007-2014), Deputy Head of the Presidential Administration of Ukraine (2014-2018), and Executive Chairman of the largest Ukrainian pharmaceutical holding Darnitsa Group (2018-2022).